Company profile for Nucleai

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nucleai’s platform unlocks spatial insights. In Nucleai Atom, your pathology slides are transformed into raw data of cell and area locations. The raw data is fed into the Nucleai engine, computing hundreds of spatial features intersected with outcome to predict drug response.We are committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI-powered image analysis...
Nucleai’s platform unlocks spatial insights. In Nucleai Atom, your pathology slides are transformed into raw data of cell and area locations. The raw data is fed into the Nucleai engine, computing hundreds of spatial features intersected with outcome to predict drug response.We are committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI-powered image analysis applications. Our platform enhances drug development, supports treatment decisions and improves patient lives.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1375 W Fulton Ave, Chicago, IL 60607, US Suite 650
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251112472697/en/Nucleai-and-University-of-Glasgow-Partner-to-Pioneer-Multimodal-Precision-Medicine-for-Colorectal-Cancer

BUSINESSWIRE
12 Nov 2025

https://www.prnewswire.com/news-releases/ai-powered-spatial-biology-workflow-from-bio-techne-and-nucleai-enables-predictive-biomarker-discovery-in-melanoma-patients-302604119.html

PR NEWSWIRE
04 Nov 2025

https://www.businesswire.com/news/home/20250422702331/en/Nucleai-Launches-First-of-its-Kind-Deep-Learning-Model-to-Automate-Spatial-Proteomics-Accelerating-Biomarker-Discovery-for-ADCs-Bispecifics-and-Immunotherapy

BUSINESSWIRE
22 Apr 2025

https://www.businesswire.com/news/home/20241105887582/en

BUSINESSWIRE
05 Nov 2024

https://www.businesswire.com/news/home/20240516792275/en

BUSINESSWIRE
16 May 2024

https://www.businesswire.com/news/home/20240408865435/en

BUSINESSWIRE
08 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty